Cargando…

Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA

OBJECTIVE: Bacteriophages (or phages) are viruses which infect and lyse bacteria. The therapeutic use of phages (phage therapy) has regained attention in the last decades as an alternative strategy to treat infections caused by antimicrobial-resistant bacteria. In clinical settings it is most likely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valente, Luca G., Federer, Lea, Iten, Manuela, Grandgirard, Denis, Leib, Stephen L., Jakob, Stephan M., Haenggi, Matthias, Cameron, David R., Que, Yok-Ai, Prazak, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474762/ https://www.ncbi.nlm.nih.gov/pubmed/34579784 http://dx.doi.org/10.1186/s13104-021-05796-1

Ejemplares similares

Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats
por: Prazak, Josef, et al.
Publicado: (2021)

Draft Genome Sequence of Methicillin-Resistant Staphylococcus aureus Strain AW7, Isolated from a Patient with Bacteremia
por: Cameron, David R., et al.
Publicado: (2019)

Progress and Pitfalls of Bacteriophage Therapy in Critical Care: A Concise Definitive Review
por: Valente, Luca, et al.
Publicado: (2021)

Efficacy assessment of a novel endolysin PlyAZ3a(T) for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model
por: Valente, Luca G., et al.
Publicado: (2022)

0356. Effect of the neuroprotective p53-inhibitor pifithrin-µ in a rodent cardiac arrest model
por: Springe, D, et al.
Publicado: (2014)

0353. Do the noble gases helium and argon exert neuroprotective effects in a rodent cardiac arrest model?
por: Zuercher, P, et al.
Publicado: (2014)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model
por: Zuercher, Patrick, et al.
Publicado: (2016)

Successful Treatment With Daptomycin of MRSA Empyema Complicated by Right-Sided Loculated Pleural Effusion Refractory to Vancomycin
por: Torjani, Ava, et al.
Publicado: (2022)

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
por: Shaw, E, et al.
Publicado: (2015)

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2023)

Do different anesthesia regimes affect hippocampal apoptosis and neurologic deficits in a rodent cardiac arrest model?
por: Bendel, Stepani, et al.
Publicado: (2015)

Description of a rat model of polymicrobial abdominal sepsis mimicking human colon perforation
por: Utiger, Julia M., et al.
Publicado: (2021)

613. Suppression of Daptomycin Resistance Development in Staphylococcus aureus Is a Class Effect of β-Lactams and Is Independent of Daptomycin–β Lactam Synergy
por: Miller, Christopher R, et al.
Publicado: (2019)

Phage Treatment Trial to Eradicate LA-MRSA from Healthy Carrier Pigs
por: Tuomala, Henni, et al.
Publicado: (2021)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
por: Roch, Melanie, et al.
Publicado: (2017)

711. Molecular Epidemiology of Daptomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Sundaram, Ayesha, et al.
Publicado: (2018)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
por: McCreary, Erin K, et al.
Publicado: (2019)

Synergy as a rationale for phage therapy using phage cocktails
por: Schmerer, Matthew, et al.
Publicado: (2014)

Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility
por: Coyne, Ashlan J. Kunz, et al.
Publicado: (2022)

EFFECTS OF M101—AN EXTRACELLULAR HEMOGLOBIN—APPLIED DURING CARDIOPULMONARY RESUSCITATION: AN EXPERIMENTAL RODENT STUDY
por: Iten, Manuela, et al.
Publicado: (2023)

Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
por: Chen, Feng-Jui, et al.
Publicado: (2018)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
por: Thitiananpakorn, Kanate, et al.
Publicado: (2020)

Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
por: Barlow, Ashley, et al.
Publicado: (2021)

Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
por: Oe, Kenichi, et al.
Publicado: (2021)

Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing
por: Mun, Su-Hyun, et al.
Publicado: (2013)

Exploring the Benefits of Metal Ions in Phage Cocktail for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
por: Li, Xinxin, et al.
Publicado: (2022)

An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection
por: Nikolic, Isidora, et al.
Publicado: (2022)

Phage-antibiotic synergy reduces Burkholderia cenocepacia population
por: Mankovich, Anna G., et al.
Publicado: (2023)

Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation
por: Bulssico, Julián, et al.
Publicado: (2023)

Isolation and characterization of bacteriophages from the human skin microbiome that infect Staphylococcus epidermidis
por: Valente, Luca G, et al.
Publicado: (2021)

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
por: Garonzik, Samira M., et al.
Publicado: (2016)

Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
por: Comeau, André M., et al.
Publicado: (2007)

Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
por: Parlato, Ciro, et al.
Publicado: (2011)

Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections
por: Nadrah, Kristina, et al.
Publicado: (2011)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
por: Chen, Liang-Yu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nif3s37bvvea8uglkk7oecg7kf